Casdin Capital, LLC Diversified Active

CIK: 0001534261 · Show all filings

Period: Q2 2019 (← Previous) (Next →)

Filing Date: Aug 13, 2019

Total Value ($000): $1,068,381,974 (100.0% shares, 0.0% debt)

Holdings (31)

SPARK THERAPEUTICS INC 8.5%
Value ($000) $90,585,824 Shares 884,800 Est. Cost $60.22 Unrealized
INVITAE CORP 8.4%
Value ($000) $90,202,118 Shares 3,838,388 Est. Cost $10040.39 Unrealized
BLUEPRINT MEDICINES CORP 8.3%
Value ($000) $88,670,200 Shares 940,000 Est. Cost $9221.69 Unrealized
CDXS CODEXIS INC 8.1%
Value ($000) $86,519,885 Shares 5,073,780 Est. Cost $13.94 Unrealized +38.3%
SAGE THERAPEUTICS INC 6.9%
Value ($000) $73,236,000 Shares 400,000 Est. Cost $89.71 Unrealized
MYOKARDIA INC 6.0%
Value ($000) $64,429,900 Shares 1,285,000 Est. Cost $39.07 Unrealized
FATE FATE THERAPEUTICS INC 4.8%
Value ($000) $51,765,000 Shares 2,550,000 Est. Cost $4.33 Unrealized +316.3%
SRPT SAREPTA THERAPEUTICS INC 4.8%
Value ($000) $50,903,250 Shares 335,000 Est. Cost $127.76 Unrealized -4.9%
BLUEBIRD BIO INC 4.4%
Value ($000) $47,382,000 Shares 372,500 Est. Cost $5243.63 Unrealized
ALNY ALNYLAM PHARMACEUTICALS INC 4.4%
Value ($000) $47,164,000 Shares 650,000 Est. Cost $81.37 Unrealized -5.7%
MAGENTA THERAPEUTICS INC 4.1%
Value ($000) $44,296,035 Shares 3,003,121 Est. Cost $1777.95 Unrealized
BLFS BIOLIFE SOLUTIONS INC 3.7%
Value ($000) $39,408,375 Shares 2,428,571 Est. Cost $15.38 Unrealized +13.3%
AUDENTES THERAPEUTICS INC 3.4%
Value ($000) $36,534,900 Shares 965,000 Est. Cost $26.14 Unrealized
VYGR VOYAGER THERAPEUTICS INC 2.9%
Value ($000) $30,706,202 Shares 1,128,075 Est. Cost $14.86 Unrealized
AGIO AGIOS PHARMACEUTICALS INC 2.3%
Value ($000) $24,690,600 Shares 495,000 Est. Cost $62.09 Unrealized -13.9%
ILMN ILLUMINA INC 2.1%
Value ($000) $22,089,000 Shares 60,000 Est. Cost $196.93 Unrealized +60.3%
GENMARK DIAGNOSTICS INC 2.0%
Value ($000) $21,838,850 Shares 3,365,000 Est. Cost $6.69 Unrealized
ADPT ADAPTIVE BIOTECHNOLOGIES COR 1.9%
Value ($000) $20,100,347 Shares 463,125 Est. Cost $44.30 Unrealized 0.0%
GRITSTONE ONCOLOGY INC 1.8%
Value ($000) $19,717,800 Shares 1,770,000 Est. Cost $4096.07 Unrealized
CONSTELLATION PHARMCETICLS I 1.8%
Value ($000) $18,714,229 Shares 1,523,960 Est. Cost $6.31 Unrealized
SGMO SANGAMO THERAPEUTICS INC 1.5%
Value ($000) $16,478,100 Shares 1,530,000 Est. Cost $8.80 Unrealized +20.9%
GLOBAL BLOOD THERAPEUTICS IN 1.5%
Value ($000) $15,780,000 Shares 300,000 Est. Cost $32.45 Unrealized
HOMOLOGY MEDICINES INC 1.4%
Value ($000) $14,579,650 Shares 745,000 Est. Cost $10386.26 Unrealized
EDIT EDITAS MEDICINE INC 1.1%
Value ($000) $11,875,200 Shares 480,000 Est. Cost $29.14 Unrealized -18.1%
ALEC ALECTOR INC 1.0%
Value ($000) $10,189,059 Shares 551,039 Est. Cost $19.47 Unrealized +4.3%
TWST TWIST BIOSCIENCE CORP 0.8%
Value ($000) $8,703,000 Shares 300,000 Est. Cost $26.45 Unrealized 0.0%
DNLI DENALI THERAPEUTICS INC 0.8%
Value ($000) $8,304,000 Shares 400,000 Est. Cost $21.34 Unrealized +5.0%
CDNA CAREDX INC 0.7%
Value ($000) $7,198,000 Shares 200,000 Est. Cost $11.47 Unrealized +179.1%
STOK STOKE THERAPEUTICS INC 0.2%
Value ($000) $2,479,450 Shares 85,000 Est. Cost $26.85 Unrealized 0.0%
TURNING POINT THERAPEUTICS I 0.2%
Value ($000) $2,442,000 Shares 60,000 Est. Cost $40700.00 Unrealized
ORCHARD THERAPEUTICS PLC 0.1%
Value ($000) $1,399,000 Shares 100,000 Est. Cost $13990.00 Unrealized